BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McCaughan GW, Koorey DJ, Strasser SI. Hepatocellular carcinoma: current approaches to diagnosis and management. Intern Med J 2002;32:394-400. [PMID: 12162396 DOI: 10.1046/j.1445-5994.2002.00227.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Gentile NM, McKenzie KM, Hurt RT. Two rare forms of hepatocellular carcinoma metastases. BMJ Case Rep 2013;2013:bcr2013008886. [PMID: 23761493 DOI: 10.1136/bcr-2013-008886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Ladd LM, Tirkes T, Tann M, Agarwal DM, Johnson MS, Tahir B, Sandrasegaran K. Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma. Clin Mol Hepatol 2016;22:450-7. [PMID: 27987537 DOI: 10.3350/cmh.2016.0036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Schuppan D, Ocker M. Integrin-mediated control of cell growth. Hepatology 2003;38:289-91. [PMID: 12883471 DOI: 10.1053/jhep.2003.50338] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
4 Archer KJ, Mas VR, David K, Maluf DG, Bornstein K, Fisher RA. Identifying genes for establishing a multigenic test for hepatocellular carcinoma surveillance in hepatitis C virus-positive cirrhotic patients. Cancer Epidemiol Biomarkers Prev 2009;18:2929-32. [PMID: 19861515 DOI: 10.1158/1055-9965.EPI-09-0767] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
5 Choi H, Loyer EM, Charnsangavej C. Neoplasms of the liver and the bile ducts. Seminars in Roentgenology 2004;39:412-27. [DOI: 10.1016/j.ro.2004.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
6 Wessner CE, Shaw CM, Stanczak M, Forsberg F, Lyshchik A, Tan A, Eisenbrey JR. Contrast-enhanced Ultrasound Identifies Patent Feeding Vessels in Transarterial Chemoembolization Patients With Residual Tumor Vascularity. Ultrasound Q 2020;36:218-23. [PMID: 32890324 DOI: 10.1097/RUQ.0000000000000513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bimonte S, Leongito M, Piccirillo M, de Angelis C, Pivonello C, Granata V, Izzo F. Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment. Infect Agent Cancer 2016;11:38. [PMID: 27525037 DOI: 10.1186/s13027-016-0082-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
8 Kono Y, Lucidarme O, Choi S, Rose SC, Hassanein TI, Alpert E, Mattrey RF. Contrast-enhanced Ultrasound as a Predictor of Treatment Efficacy within 2 Weeks after Transarterial Chemoembolization of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2007;18:57-65. [DOI: 10.1016/j.jvir.2006.10.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
9 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol 2010; 2(11): 417-424 [PMID: 21179308 DOI: 10.4329/wjr.v2.i11.417] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
10 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol. 2010;2:417-424. [PMID: 21179308 DOI: 10.4329/wjr.v2.ill.417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Koorey D. Hepatocellular carcinoma: prevention, detection and treatment … in the real world. Internal Medicine Journal 2007;37:513-5. [DOI: 10.1111/j.1445-5994.2007.01439.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
12 Li G, Yuan L, Liu D, Liu J. Upregulation of Leucine Zipper Protein mRNA in Hepatocellular Carcinoma Associated With Poor Prognosis. Technol Cancer Res Treat 2016;15:517-22. [PMID: 26031464 DOI: 10.1177/1533034615587432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Archer KJ, Zhao Z, Guennel T, Maluf DG, Fisher RA, Mas VR. Identifying genes progressively silenced in preneoplastic and neoplastic liver tissues. Int J Comput Biol Drug Des 2010;3:52-67. [PMID: 20693610 DOI: 10.1504/IJCBDD.2010.034499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Archer KJ, Mas VR, Maluf DG, Fisher RA. High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Mol Genet Genomics. 2010;283:341-349. [PMID: 20165882 DOI: 10.1007/s00438-010-0522-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]